Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

ClinicalTrials.gov ID: NCT00699582

Public ClinicalTrials.gov record NCT00699582. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 7:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy, safety and tolerability of perampanel when given as an adjunctive therapy in subjects with refractory partial seizures.

Study identification

NCT ID
NCT00699582
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eisai Inc.
Industry
Enrollment
389 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2008 (Type not available)
Primary completion
Dec 2010 (Actual)
Completion
Jan 2011 (Actual)
Last update posted
Jul 11, 2014

2008 – 2011

United States locations

U.S. sites
32
U.S. states
12
U.S. cities
20
Facility City State ZIP Site status
North Alabama Neuroscience Research Associates Huntsville Alabama 35801 —
Not listed Huntsville Alabama — —
Xenoscience, Inc. Phoenix Arizona 85004 —
Not listed Phoenix Arizona — —
University of Arizona Tucson Arizona 85724 —
Not listed Tucson Arizona — —
Not listed Fresno California — —
Not listed Sacramento California — —
Neurosearch II, Inc. Ventura California 93003 —
Not listed Ventura California — —
Mile High Research Center Denver Colorado 80218 —
Neurology Associates of Northern Colorado Fort Collins Colorado 80524 —
Not listed Fort Collins Colorado — —
Mayo Clinic-Jacksonville Jacksonville Florida 32224 —
Not listed Jacksonville Florida — —
Not listed Boston Massachusetts — —
Not listed Burlington Massachusetts — —
Neurological Research Center at Hattiesburg Clinic Hattiesburg Mississippi 39401 —
Not listed Hattiesburg Mississippi — —
The Comprehensive Care Center for Children And Adults Chesterfield Missouri 63017 —
Not listed Chesterfield Missouri — —
Saint Luke's Comprehensive Epilepsy Center Kansas City Missouri 64111 —
Not listed Kansas City Missouri — —
Not listed Buffalo New York — —
NYU Comprehensive Epilepsy Center New York New York 10016 —
Not listed New York New York — —
SUNY Upstate Medical University Syracuse New York 13210 —
Not listed Syracuse New York — —
Not listed Dallas Texas — —
Not listed Salt Lake City Utah — —
Dean Foundation for Health, Research and Education, Inc. Madison Wisconsin 53715 —
Not listed Madison Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 60 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00699582, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 11, 2014 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00699582 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →